- Gennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding Moneycontrol
- Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine The Indian Express
- AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses CEPI
- Emcure Pharma arm Gennova advances development of Nipah virus vaccine Medical Dialogues
- Gennova Biopharma partners with CEPI to develop mRNA Nipah vaccine Business Standard
Gennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding MoneycontrolPune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine The Indian ExpressAI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses CEPIEmcure Pharma arm Gennova advances development of Nipah virus vaccine Medical DialoguesGennova Biopharma partners with CEPI to develop mRNA Nipah vaccine Business Standard Top stories – Google News